Searched for
VENLAFAXINE HYDROCHLORIDE
Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- After long phase of consolidation: 4 Indian pharma stocks with upside potential of up to 41%Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Aurobindo recalls 47,000 bottles of antidepressant capsules in USThe US arm of Aurobindo Pharma is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules, manufactured by the Hyde...
- Sun Pharma recalls 68,194 bottles of anti-depression drug in USThe 37.5 mg tablets in 30-count bottles and 90-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol for Sun Pharma Gl...
- USFDA raps Sun Pharmaceuticals for delay in follow-up for recalled drugs from US marketThe inspectors chided the firm for not documenting alarm events that occur during the routine tablet compression, among other observations.
- Sun Pharmaceutical's woes deepen as US arm Taro recalls Warfarin from marketsThis is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in March this year to create the world's fifth...
- Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US salesThe facility is important for the company as its contributes to around 40 per cent of US sales and around 25 per cent of consolidated profi...
- Sun Pharma unit recalls mutiple lots of capsules from USCaraco Pharmaceutical Laboratories , a unit of Sun Pharma, has initiated a recall of multiple lots of Cephalexin capsules from the US marke...
- Sensex rangebound, Nifty below 7450; top ten stocks in focus"Nifty has an immediate support at 7450 but any move below this level will initiate fresh short positions," LKP said in a report.
- Ten stocks in focus in Monday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Sun Pharmaceutical Industries recalls Venlafaxine Hydrochloride after failing a dissolution testThe recall was made by Sun Pharma’s US subsidiary Caraco Pharmaceutical Laboratories for drugs manufactured in the company’s Indian facilit...
- Sun Pharma subsidiary recalls some lots of antidepressant drug Venlafaxine Hydrochloride from US marketVenlafaxine Hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder.
- Sun Pharma recalls over 4 lakh bottles of two drugs in USDrug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet spe...
- Dr Reddy’s Labs launches three generic products in USADr Reddy’s Laboratories announced today that it launched three generic drugs in the US market.
- Aurobindo Pharma gets USFDA nod for anti-depression capsulesThe product has a global market size of about USD 2.4 billion for the twelve months ending September 2010 according to IMS study group.
- Citigroup puts 'hold' on Sun PharmaWhile Sun is entitled to 180 days exclusivity, thanks to the long delay in getting approval and full genericisation of the capsule form lik...
- Sun Pharma receives USFDA nod for Venlafaxine tabletsSun Pharmaceuticals Industries Ltd has received USFDA's approval to market a generic version of Venlafaxine Hydrochloride Extended Release ...
- Cadila bags USFDA nod for 3 productsPharmaceutical firm, Cadila Healthcare today said USFDA has given its nod it for the company's three products, taking the group's total num...
Load More
